TrademarkOpen
Search / United States / 97272829

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

AUGTYRO

Registered
Used for: Pharmaceutical preparations for the treatment of cancer

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 21 Feb 2022
    Application filed
    New Application Entered
  2. 1 Dec 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 2 Dec 2022
    Office action issued
    Non-Final Action Written
  4. 26 May 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 28 May 2023
    Approved for publication
    Approved For Pub - Principal Register
  6. 11 Jul 2023
    Published for opposition
    Published For Opposition
  7. 5 Sep 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 26 Feb 2024
    Statement of use filed
    Teas Statement Of Use Received
  9. 7 Apr 2024
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  10. 9 Apr 2024
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  11. 14 May 2024
    Registered on the Principal Register
    Registered-Principal Register
All 30 events
2024-05-14Registered-Principal Register
2024-05-14Notice Of Registration Confirmation Emailed
2024-04-09Notice Of Acceptance Of Statement Of Use E-Mailed
2024-04-07Allowed Principal Register - Sou Accepted
2024-03-18Case Assigned To Intent To Use Paralegal
2024-03-18Statement Of Use Processing Complete
2024-02-26Teas Statement Of Use Received
2024-02-26Use Amendment Filed
2023-09-05Noa Mailed - Sou Required From Applicant
2023-07-11Published For Opposition
2023-07-11Official Gazette Publication Confirmation E-Mailed
2023-06-21Notification Of Notice Of Publication E-Mailed
2023-06-07Electronic Record Review Complete
2023-06-02On Hold - Electronic Record Review Required
2023-05-28Approved For Pub - Principal Register
2023-05-27Teas/Email Correspondence Entered
2023-05-26Teas Response To Office Action Received
2023-05-26Correspondence Received In Law Office
2022-12-02Non-Final Action Written
2022-12-02Non-Final Action Written
2022-12-02Non-Final Action E-Mailed
2022-12-02Notification Of Non-Final Action E-Mailed
2022-12-01Assigned To Examiner
2022-09-09Teas Change Of Owner Address Received
2022-09-09Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2022-09-09Attorney/Dom.rep.revoked And/Or Appointed
2022-09-09Teas Change Of Correspondence Received
2022-09-09Applicant/Correspondence Changes (Non-Responsive) Entered
2022-02-23New Application Office Supplied Data Entered
2022-02-21New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of cancer

First use anywhere 5 Dec 2023 · First use in commerce 5 Dec 2023

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 14 May 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.